Loading...
•
Dec 31, 2019
CervoMed Q4 2019 Earnings Report
Announced the retirement of Chief Science Officer John L. Gainer, who will remain on the board of directors.
Key Takeaways
Diffusion Pharmaceuticals announced the retirement of Chief Science Officer John L. Gainer, who will continue to serve as an advisor and board member. The company has begun searching for a Chief Medical Officer to replace the Chief Science Officer position.
Professor John L. Gainer, the company’s chief science officer, is retiring.
Dr. Gainer will continue to serve as an advisor and member of the board of directors.
The Company has begun a search for a Chief Medical Officer as a replacement for the former Chief Science Officer position.
Diffusion’s on-ambulance PHAST-TSC trial for acute stroke has begun patient enrollment.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...